Work Experience
Xiaoqiang Ding practices in Zhongshan, China. Their top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, IgA Nephropathy, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.
Research Interests
Their clinical research consists of co-authoring 264 peer reviewed articles in the past 15 years.
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Selected Publications
1. Jia P, Wu X, Dai Y, Teng J, Fang Y, Hu J, Zou J, Liang M,Ding X#. miR-21 Is Required for Local and Remote Ischemic Preconditioning in Multi-organ Protection against Sepsis.Crit Care Med. 2017, 45(7):e703-e710.
2.Jiang W, Teng J, Xu J, Shen B, Wang Y, Fang Y, Zou Z, Jin J, Zhuang Y, Liu L, Luo Z, Wang C,Ding X#. Dynamic Predictive Scores for Cardiac Surgery-Associated Acute Kidney Injury.J Am Heart Assoc, 2016, 5(8):e003754
3. Cao XS, Chen J, Zou JZ, Zhong YH, Teng J, Ji J, Chen ZW, Liu ZH, Shen B, Nie YX, Lv WL, Xiang FF, Tan X,Ding X#. Association of indoxyl sulfate with heart failure among patients on hemodialysis.Clin J Am Soc Nephrol. 2015, 10(1):111-9.
4. Xu X, Kriegel AJ, Liu Y, Usa K, Mladinov D, Liu H, Fang Y,Ding X#, Liang M. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21.Kidney Int. 2012, 82:1167-75.
5. Cao CC,Ding X#, Ou ZL. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.Kidney Int. 2004, 65: 834-45.
